| 1 |
2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative
Daniel Aletaha et al. · Arthritis & Rheumatism
Open access |
10 Aug 2010 |
9,731 |
| 2 |
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
Daniel J. Klionsky et al. · Autophagy
Open access2,467 authors |
2 Jan 2016 |
6,023 |
| 3 |
Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck
James A. Bonner, Paul M. Harari, J. Giralt et al. · New England Journal of Medicine
Open access |
8 Feb 2006 |
5,137 |
| 4 |
Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer
David Cunningham, Yves Humblet, Salvatore Siena et al. · New England Journal of Medicine
Open access |
21 Jul 2004 |
5,071 |
| 5 |
Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
Eric Van Cutsem, Claus-Henning Köhne, Erika Hitre et al. · New England Journal of Medicine
Open access |
Apr 2009 |
3,899 |
| 6 |
Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer
Jan B. Vermorken, Ricard Mesı́a, Fernando Rivera et al. · New England Journal of Medicine
Open access |
10 Sep 2008 |
3,762 |
| 7 |
Meta-analyses involving cross-over trials: methodological issues
Diana Ruth Elbourne, Douglas G. Altman, Julian P. T. Higgins et al. · International Journal of Epidemiology
Open access |
Feb 2002 |
2,318 |
| 8 |
Crystal Structure of the Extracellular Segment of Integrin αVβ3 in Complex with an Arg-Gly-Asp Ligand
Jian-Ping Xiong, Thilo Stehle, Rongguang Zhang et al. · Science
|
5 Apr 2002 |
1,616 |
| 9 |
Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial
Robert Pirker, Jose R. Pereira, Aleksandra Szczęsna et al. · The Lancet
Open access |
May 2009 |
1,360 |
| 10 |
Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME
Patrício Godoy et al. · Archives of Toxicology
Open access |
Aug 2013 |
1,303 |
| 11 |
Crystal Structure of the Extracellular Segment of Integrin αVβ3
Jian-Ping Xiong, Thilo Stehle, Beate Diefenbach et al. · Science
Open access |
12 Oct 2001 |
1,285 |
| 12 |
Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial
Howard L. Kaufman, Jeffery Scott Russell, Omid Hamid et al. · The Lancet Oncology
Open access |
7 Sep 2016 |
1,235 |
| 13 |
Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial
Roger Stupp et al. · The Lancet Oncology
Open access |
19 Aug 2014 |
1,053 |
| 14 |
NCCN Guidelines Insights: Colon Cancer, Version 2.2018
Al B. Benson et al. · Journal of the National Comprehensive Cancer Network
Open access |
Apr 2018 |
1,045 |
| 15 |
Interactions between Autophagy Receptors and Ubiquitin-like Proteins Form the Molecular Basis for Selective Autophagy
Vladimir V. Rogov, Volker Dötsch, Terje Johansen et al. · Molecular Cell
Open access |
2014 |
1,018 |
| 16 |
Metabolism and Kinetics of Bisphenol A in Humans at Low Doses Following Oral Administration
Wolfgang Völkel, Thomas Colnot, György András Csanády et al. · Chemical Research in Toxicology
|
24 Sep 2002 |
1,006 |
| 17 |
Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphoma
Robert Chen, Pier Luigi Zinzani, Michelle A. Fanale et al. · Journal of Clinical Oncology
Open access |
25 Apr 2017 |
998 |
| 18 |
On the use of vinylene carbonate (VC) as an additive to electrolyte solutions for Li-ion batteries
Doron Aurbach, K. Gamolsky, Boris Markovsky et al. · Electrochimica Acta
|
Feb 2002 |
992 |
| 19 |
Nonradiating anapole modes in dielectric nanoparticles
Andrey E. Miroshnichenko, Andrey B. Evlyukhin, Yefeng Yu et al. · Nature Communications
Open access |
27 Aug 2015 |
992 |
| 20 |
Minimum Information about a Biosynthetic Gene cluster
Marnix H. Medema et al. · Nature Chemical Biology
Open access154 authors |
18 Aug 2015 |
927 |
| 21 |
The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin
Bernd Greiner, Michel F Eichelbaum, Péter Fritz et al. · Journal of Clinical Investigation
Open access |
15 Jul 1999 |
921 |
| 22 |
Tepotinib in Non–Small-Cell Lung Cancer with MET Exon 14 Skipping Mutations
Paul K. Paik et al. · New England Journal of Medicine
Open access |
28 May 2020 |
891 |
| 23 |
International Union of Basic and Clinical Pharmacology. LXXXIX. Update on the Extended Family of Chemokine Receptors and Introducing a New Nomenclature for Atypical Chemokine Receptors
Françoise Bachelerie et al. · Pharmacological Reviews
Open access |
11 Nov 2013 |
872 |
| 24 |
Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial
Florian Lordick, Yoon‐Koo Kang, Hyun Cheol Chung et al. · The Lancet Oncology
Open access |
17 Apr 2013 |
842 |
| 25 |
N -Methylated Cyclic RGD Peptides as Highly Active and Selective α V β 3 Integrin Antagonists
Michael A. Dechantsreiter, Eckart Planker, Barbara Mathä et al. · Journal of Medicinal Chemistry
Open access |
24 Jul 1999 |
840 |
| 26 |
Efficacy according to biomarker status of cetuximab plus FOLFOX-4 as first-line treatment for metastatic colorectal cancer: the OPUS study
Carsten Bokemeyer, Igor Bondarenko, J.T. Hartmann et al. · Annals of Oncology
Open access |
12 Jan 2011 |
786 |
| 27 |
Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study
Luc Yves Dirix, István Takács, Guy Jérusalem et al. · Breast Cancer Research and Treatment
Open access |
23 Oct 2017 |
764 |
| 28 |
LIGSITE: automatic and efficient detection of potential small molecule-binding sites in proteins
Manfred Hendlich, Friedrich Rippmann, Gerhard Barnickel · Journal of Molecular Graphics and Modelling
|
Dec 1997 |
752 |
| 29 |
Primary Hepatocytes: Current Understanding of the Regulation of Metabolic Enzymes and Transporter Proteins, and Pharmaceutical Practice for the Use of Hepatocytes in Metabolism, Enzyme Induction, Transporter, Clearance, and Hepatotoxicity Studies
Nicola J. Hewitt, María José Gómez Lechón, J. Brian Houston et al. · Drug Metabolism Reviews
|
2007 |
735 |
| 30 |
Prognostic and Predictive Relevance of Primary Tumor Location in Patients With RAS Wild-Type Metastatic Colorectal Cancer
Sabine Tejpar, Sebastian Stintzing, Fortunato Ciardiello et al. · JAMA Oncology
Open access |
10 Oct 2016 |
730 |
| 31 |
PRODRG, a program for generating molecular topologies and unique molecular descriptors from coordinates of small molecules
Daan M. F. van Aalten, R. P. Bywater, J. B. C. Findlay et al. · Journal of Computer-Aided Molecular Design
|
Jun 1996 |
721 |
| 32 |
MET Exon 14 Mutations in Non–Small-Cell Lung Cancer Are Associated With Advanced Age and Stage-Dependent MET Genomic Amplification and c-Met Overexpression
Mark Magdi Awad, Geoffrey R. Oxnard, David Michael Jackman et al. · Journal of Clinical Oncology
Open access |
5 Jan 2016 |
706 |
| 33 |
Nucleotide exchange factor GEF-H1 mediates cross-talk between microtubules and the actin cytoskeleton
Mira Krendel, Frank T. Zenke, Gary Bokoch · Nature Cell Biology
|
25 Mar 2002 |
685 |
| 34 |
Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials
Chantal Quinten, Corneel Coens, Murielle E.L. Mauer et al. · The Lancet Oncology
Review |
19 Aug 2009 |
662 |
| 35 |
Proliferative and Nonproliferative Lesions of the Rat and Mouse Hepatobiliary System
Bob Thoolen, Robert R. Maronpot, Takanori Harada et al. · Toxicologic Pathology
Open access |
Dec 2010 |
659 |
| 36 |
Common Electroanalytical Behavior of Li Intercalation Processes into Graphite and Transition Metal Oxides
Doron Aurbach, Mikhail D. Levi, Elena Levi et al. · Journal of The Electrochemical Society
|
Sep 1998 |
652 |
| 37 |
Massenspektrometrie
B. Güssregen · Springer Reference Medizin
Book chapter |
2019 |
649 |
| 38 |
Proteinase K from Tritirachium album Limber
W. Ebeling, N. Hennrich, Michael Klockow et al. · European Journal of Biochemistry
|
Aug 1974 |
648 |
| 39 |
Solid‐State Electrochemical Kinetics of Li‐Ion Intercalation into Li1 − x CoO2: Simultaneous Application of Electroanalytical Techniques SSCV, PITT, and EIS
Mikhael D. Levi, Gregory Salitra, Boris Markovsky et al. · Journal of The Electrochemical Society
|
Apr 1999 |
644 |
| 40 |
Randomized, comparative study of interferon β-1a treatment regimens in MS
HILLEL S. PANITCH, Douglas S. Goodin, G. Francis et al. · Neurology
|
26 Nov 2002 |
638 |
| 41 |
DoGSiteScorer: a web server for automatic binding site prediction, analysis and druggability assessment
Andrea Volkamer, Daniel Kühn, Friedrich Rippmann et al. · Bioinformatics
Open access |
23 May 2012 |
625 |
| 42 |
Converting a Peptide into a Drug: Strategies to Improve Stability and Bioavailability
Céline Adessi, Claudio Soto · Current Medicinal Chemistry
|
May 2002 |
615 |
| 43 |
Comparison of the Effect of Denosumab and Alendronate on BMD and Biochemical Markers of Bone Turnover in Postmenopausal Women With Low Bone Mass: A Randomized, Blinded, Phase 3 Trial
Jacques P. Brown, Richard Lewis Prince, Chad L. Deal et al. · Journal of Bone and Mineral Research
|
16 Dec 2008 |
609 |
| 44 |
Addition of cetuximab to chemotherapy as first-line treatment for KRAS wild-type metastatic colorectal cancer: Pooled analysis of the CRYSTAL and OPUS randomised clinical trials
Carsten Bokemeyer, Eric Van Cutsem, Philippe Rougier et al. · European Journal of Cancer
|
23 Mar 2012 |
598 |
| 45 |
Safety and Clinical Activity of Pembrolizumab and Multisite Stereotactic Body Radiotherapy in Patients With Advanced Solid Tumors
Jason J. Luke, Jeffrey M. Lemons, Theodore G Karrison et al. · Journal of Clinical Oncology
Open access |
13 Feb 2018 |
597 |
| 46 |
Amyloid beta oligomers induce impairment of neuronal insulin receptors
Weiqin Zhao, Fernanda G. De Felice, Sara J. Fernandez et al. · The FASEB Journal
|
24 Aug 2007 |
591 |
| 47 |
Alternative (non-animal) methods for cosmetics testing: current status and future prospects—2010
Sarah Adler et al. · Archives of Toxicology
Open access |
30 Apr 2011 |
585 |
| 48 |
RANTES Deposition by Platelets Triggers Monocyte Arrest on Inflamed and Atherosclerotic Endothelium
Philipp von Hundelshausen, Kim S. C. Weber, Yuqing Huo et al. · Circulation
|
3 Apr 2001 |
584 |
| 49 |
Structural and Functional Aspects of RGD-Containing Cyclic Pentapeptides as Highly Potent and Selective Integrin αVβ3Antagonists
Roland Haubner, Rainer Gratias, Beate Diefenbach et al. · Journal of the American Chemical Society
|
1996 |
582 |
| 50 |
EGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer: analysis of data from the phase 3 FLEX study
Robert Pirker, Jose R. Pereira, Joachim von Pawel et al. · The Lancet Oncology
|
5 Nov 2011 |
580 |